Optic nerve glioma overview

Revision as of 13:38, 5 October 2015 by Simrat Sarai (talk | contribs)
Jump to navigation Jump to search

Optic nerve glioma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Optic nerve glioma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Optic nerve glioma overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Optic nerve glioma overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Optic nerve glioma overview

CDC on Optic nerve glioma overview

Optic nerve glioma overview in the news

Blogs on Optic nerve glioma overview

Directions to Hospitals Treating Optic nerve glioma

Risk calculators and risk factors for Optic nerve glioma overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2]

Overview

Optic nerve glioma is common tumor of the optic nerve. Majority of these tumors are benign but malignant gliomas of the optic nerve can occur. Optic nerve glioma is a slow-growing brain tumor that arises in or around the optic nerves. As the tumor progresses, it can press on the optic nerve and worsen a child's vision.

Classification

Optic pathway gliomas are classified under the WHO’s classification of a grade I pilocytic astrocytoma, usually Juvenile Pilocytic Astrocytomas (JPA). Occasionally pathology is positive for grade II fibrillary astrocytoma. Optic nerve gliomas may be classified into two subtypes based on anatomic location, and whether or not they are associated with neurofibromatosis type 1. Optic nerve gliomas may be classified according to anatomic location into two subtypes: anterior tumors and posterior tumors.

Pathophysiology

Genes involved in the pathogenesis of optic nerve glioma include BRAF-KIAA, tumor suppressor genes and chromosomes 7q34 and 17q. On gross pathology, smooth and fusiform intradural lesion is characteristic findings of optic nerve glioma. On microscopic histopathological analysis, low grade spindle shaped pilocytic astrocytes & glial filaments, with the presence of numerous Rosenthal’s fibers are characteristic findings of optic nerve gliomas.

Causes

There is no established cause for optic nerve glioma.

Differential Diagnosis

Optic nerve glioma must be differentiated from other diseases that cause optic nerve enlargement and tumors located at optic chiasm, such as optic nerve meningioma, orbital pseudotumor, optic neuritis, orbital lymphomas, metastasis, fibrous dysplasia, paranasal mucocele, Lymphoma, rhabdomyosarcoma, neurofibromatosis, perioptic haemorrhage, erdheim-Chester disease, juvenile xanthogranuloma, medulloepithelioma, retinoblastoma, krabbe disease, optic nerve and chiasm glioma such as germinoma and sarcoidosis, and optic chiasm glioma extending into the hypothalamus such as pituitary adenoma, craniopharyngioma, malignant astrocytoma, dermoid cyst, chordoma, colloid cyst, fibrous dyplasia, sarcoidosis, histiocytosis X, tuberculous granuloma, and hemangloendothelioma.[1]

Epidemiology and Demographics

The prevalence of optic nerve glioma is estimated to be 1 per 100, 000 patients presenting with eye complaints. Optic nerve gliomas affects girls and boys equally. There is no racial predilection to the optic nerve glioma.[2]

Risk Factors

There are no established risk factors for optic nerve gliomas.

Screening

According to the United States Preventive Services Task Force, screening for optic nerve glioma is not recommended. It is recommended that all children with NF-1 have their vision checked every year by an ophthalmologist.

Natural History, Complications and Prognosis

If left untreated, less than 5 percentage of patients with optic nerve gliomas may progress to develop blindness. Common complications of optic nerve glioma include decreased vision, blindness, growth hormone deficiency, precocious puberty, and hydrocephalus. Prognosis is generally good in most patients with optic pathway gliomas. Most optic nerve gliomas are benign and produce slowly progressive visual loss associated with variable proptosis and anterior or posterior optic neuropathy.

History and Symptoms

Symptoms of optic nerve glioma include proptosis, unilaterl or bilateral visual impairment, nystagmus, squinting, obstructive hydrocephalus and diencephalic syndrome.

Physical Examination

Common physical examination findings of optic nerve glioma include nystagmus, strabismus, proptosis, visual impairment, afferent pupillary defect, edema and/or pallor of optic disc, torticollis and deficits of cranial nerve II.

Laboratory Findings

There are no diagnostic lab findings associated with optic nerve glioma.

Electrocardiogram

There are no electrocardiogram findings associated with optic nerve glioma.

Chest X Ray

There are no chest x ray findings associated with optic nerve glioma.

CT Scan

On Head and neck CT, optic nerve glioma is characterized by variably enlarged and elongated optic nerve with kinking or buckling.

MRI Scan

On Head and neck MRI, optic nerve glioma is characterized by isointense to hypointense mass on T1-weighted MRI, and hyperintense mass on T2-weighted MRI.

Echocardiography

There are no echocardiography findings associated with optic nerve glioma.

References

  1. "Radiopedia diffential diagnosis optic glioma".
  2. "Radiopedia optic glioma epidemiology".

Template:WH Template:WS